VTR

$84.801.30%1.09

Ventas Inc (VTR)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$83.71

Offen:

$84.97

24-Stunden-Volumen:

5,218,535

Relatives Volumen:

1.41

Marktkapitalisierung:

$44.84B

Einnahmen:

$6.13B

Nettoeinkommen (Verlust:

$272.21M

KGV:

153.60

EPS:

$0.5521

Netto-Cashflow:

$1.38B

1W Leistung:

-3.00%

1M Leistung:

+0.94%

6M Leistung:

-3.66%

1Y Leistung:

+14.92%

1-Tages-Spanne:

$0.00$0.00

1-Wochen-Bereich:

$76.75$86.93

52-Wochen-Spanne:

$68.15$101.60

Ventas Inc Aktie (VTR) Unternehmensprofil

Firmenname

Ventas Inc

Sektor

Real Estate

Branche

REIT - Healthcare Facilities

Telefon

(312) 660-3800

Adresse

300 N LASALLE STREET, CHICAGO, IL, USA

Mitarbeiter

542

Nächster Verdiensttermin

null

Neueste SEC-Einreichungen

SEC

VTR-Diskussionen auf X

VTR vs. WELL, OHI, DOC, AHR vergleichen

Aktien	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VTR Ventas Inc	$44.84B	$6.13B	$272.21M	$1.38B	$0.5521
WELL Welltower Inc	$172.10B	$11.75B	$1.46B	$2.19B	-$0.6014
OHI Omega Healthcare Investors Inc	$14.24B	$1.24B	$655.98M	$857.80M	$2.06
DOC Healthpeak Properties Inc	$13.12B	$2.87B	$250.10M	$1.13B	$0.3188
AHR American Healthcare Reit Inc	$11.67B	$2.37B	$101.67M	$169.19M	$0.5775

Ventas Inc Aktie (VTR) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-09-15	Resumed	Jefferies	Buy
2026-07-07	Eingeleitet	Barclays	Equal Weight
2026-06-17	Resumed	Raymond James	Outperform
2026-01-09	Eingeleitet	Goldman	Buy
2025-10-01	Eingeleitet	Cantor Fitzgerald	Overweight
2025-09-19	Eingeleitet	UBS	Neutral
2025-06-23	Hochstufung	JP Morgan	Neutral → Overweight
2025-03-07	Hochstufung	Argus	Hold → Buy
2025-01-17	Hochstufung	Robert W. Baird	Neutral → Outperform
2024-10-01	Hochstufung	Wells Fargo	Equal Weight → Overweight
2024-03-18	Hochstufung	Evercore ISI	In-line → Outperform
2024-02-26	Herabstufung	Wells Fargo	Overweight → Equal Weight
2024-01-30	Eingeleitet	Deutsche Bank	Buy
2024-01-16	Hochstufung	BofA Securities	Neutral → Buy
2023-11-07	Hochstufung	Wedbush	Neutral → Outperform
2023-10-11	Eingeleitet	Exane BNP Paribas	Outperform
2023-10-03	Eingeleitet	Wedbush	Neutral
2023-09-20	Herabstufung	Raymond James	Strong Buy → Outperform
2023-08-11	Herabstufung	BofA Securities	Buy → Neutral
2023-06-23	Hochstufung	Raymond James	Outperform → Strong Buy
2023-04-20	Eingeleitet	Wells Fargo	Overweight
2022-11-01	Bestätigt	Credit Suisse	Outperform
2022-11-01	Herabstufung	Raymond James	Strong Buy → Outperform
2022-10-10	Herabstufung	Robert W. Baird	Outperform → Neutral
2022-06-30	Hochstufung	Jefferies	Hold → Buy
2022-06-23	Eingeleitet	Credit Suisse	Outperform
2022-06-03	Eingeleitet	CapitalOne	Overweight
2022-05-18	Hochstufung	Credit Suisse	Neutral → Outperform
2022-03-11	Hochstufung	BMO Capital Markets	Market Perform → Outperform
2022-03-11	Hochstufung	BofA Securities	Neutral → Buy
2022-02-01	Eingeleitet	Credit Suisse	Neutral
2022-01-20	Hochstufung	Mizuho	Neutral → Buy
2021-12-14	Hochstufung	Citigroup	Neutral → Buy
2021-11-22	Herabstufung	SMBC Nikko	Outperform → Neutral
2021-10-04	Resumed	Morgan Stanley	Equal-Weight
2021-09-23	Hochstufung	Raymond James	Outperform → Strong Buy
2021-09-07	Hochstufung	Deutsche Bank	Hold → Buy
2021-08-26	Hochstufung	BMO Capital Markets	Underperform → Market Perform
2021-07-14	Resumed	Mizuho	Neutral
2021-06-15	Eingeleitet	Wolfe Research	Outperform
2021-06-11	Hochstufung	Barclays	Equal Weight → Overweight
2021-05-13	Hochstufung	KeyBanc Capital Markets	Underweight → Overweight
2021-05-13	Hochstufung	Robert W. Baird	Neutral → Outperform
2021-01-08	Herabstufung	BMO Capital Markets	Market Perform → Underperform
2021-01-06	Eingeleitet	Robert W. Baird	Neutral
2020-11-30	Hochstufung	BofA Securities	Underperform → Buy
2020-11-10	Hochstufung	Jefferies	Underperform → Hold
2020-09-08	Herabstufung	Argus	Buy → Hold
2020-09-02	Resumed	Stifel	Hold
2020-08-20	Herabstufung	Raymond James	Strong Buy → Outperform
2020-08-14	Hochstufung	Evercore ISI	Underperform → In-line
2020-08-14	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2020-06-15	Herabstufung	Evercore ISI	In-line → Underperform
2020-03-25	Hochstufung	Raymond James	Mkt Perform → Strong Buy
2020-03-23	Herabstufung	BofA/Merrill	Neutral → Underperform
2020-03-10	Herabstufung	Jefferies	Buy → Underperform
2020-02-28	Hochstufung	Raymond James	Underperform → Mkt Perform
2020-01-22	Herabstufung	Raymond James	Mkt Perform → Underperform
2020-01-17	Hochstufung	Jefferies	Hold → Buy
2019-12-20	Resumed	Mizuho	Neutral
2019-12-10	Herabstufung	Wells Fargo	Market Perform → Underperform
2019-11-19	Hochstufung	Argus	Hold → Buy
2019-10-30	Herabstufung	Stifel	Buy → Hold
2019-10-28	Herabstufung	CapitalOne	Overweight → Equal Weight
2019-10-28	Herabstufung	Citigroup	Buy → Neutral

Finanzdaten der Ventas Inc-Aktie (VTR)

Zeitraum	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Enddatum des Zeitraums	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	5,833.98	4,924.27	4,497.83	4,129.19	3,828.01
Operating expenses USD (M)	5,629.66	4,932.26	4,613.41	4,223.33	3,990.39
Operating income USD (M)	-	-	-115.58	-94.14	-162.39
Income before tax USD (M)	204.32	-8.00	-115.58	-94.14	-162.39
Income tax expense USD (M)	-14.15	-37.78	-9.54	-16.93	4.83
Net income USD (M)	261.52	88.35	-30.30	-40.93	56.56
Basic EPS USD/shares	0.55	0.20	-0.10	-0.12	0.13
Diluted EPS USD/shares	0.54	0.19	-0.10	-0.12	0.13
Basic weighted shares shares (M)	455.08	411.77	401.81	373.37	382.79
Diluted weighted shares shares (M)	462.62	416.37	405.67	403.45	386.30

Ventas Inc-Aktie (VTR) Insiderhandel

Walter C. RakowichMay 14 '26
Director
Transaktion
Proposed Sale
Kosten
$90.16
#Aktien
1,152
Wert ($)
103,864
#Aktien Gesamt
0
RAKOWICH WALTER CMay 14 '26
Director
Transaktion
Sale
Kosten
$90.20
#Aktien
1,152
Wert ($)
103,915
#Aktien Gesamt
28,349
GREGORY LIEBBEMar 02 '26
Officer
Transaktion
Proposed Sale
Kosten
$86.31
#Aktien
17,248
Wert ($)
1,488,620
#Aktien Gesamt
0
Roberts Carey S.Feb 11 '26
EVP and GC
Transaktion
Sale
Kosten
$85.00
#Aktien
35,532
Wert ($)
3,020,117
#Aktien Gesamt
72,755
CAREY SHEA ROBERTSFeb 11 '26
Officer
Transaktion
Proposed Sale
Kosten
$85.00
#Aktien
35,532
Wert ($)
3,020,117
#Aktien Gesamt
0
CAFARO DEBRA AFeb 06 '26
Chairman and CEO
Transaktion
Option Exercise
Kosten
$73.71
#Aktien
10,322
Wert ($)
760,835
#Aktien Gesamt
1,124,356
CAFARO DEBRA AFeb 06 '26
Chairman and CEO
Transaktion
Sale
Kosten
$82.23
#Aktien
10,322
Wert ($)
848,751
#Aktien Gesamt
1,114,034
CAFARO DEBRA AFeb 06 '26
Officer
Transaktion
Proposed Sale
Kosten
$82.23
#Aktien
10,322
Wert ($)
848,751
#Aktien Gesamt
0
CAFARO DEBRA AFeb 02 '26
Chairman and CEO
Transaktion
Option Exercise
Kosten
$73.71
#Aktien
10,322
Wert ($)
760,835
#Aktien Gesamt
1,124,356
CAFARO DEBRA AFeb 02 '26
Chairman and CEO
Transaktion
Sale
Kosten
$77.66
#Aktien
10,322
Wert ($)
801,605
#Aktien Gesamt
1,114,034

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Walter C. Rakowich	Director	May 14 '26	Proposed Sale	$90.16	1,152	103,864	0
RAKOWICH WALTER C	Director	May 14 '26	Sale	$90.20	1,152	103,915	28,349
GREGORY LIEBBE	Officer	Mar 02 '26	Proposed Sale	$86.31	17,248	1,488,620	0
Roberts Carey S.	EVP and GC	Feb 11 '26	Sale	$85.00	35,532	3,020,117	72,755
CAREY SHEA ROBERTS	Officer	Feb 11 '26	Proposed Sale	$85.00	35,532	3,020,117	0
CAFARO DEBRA A	Chairman and CEO	Feb 06 '26	Option Exercise	$73.71	10,322	760,835	1,124,356
CAFARO DEBRA A	Chairman and CEO	Feb 06 '26	Sale	$82.23	10,322	848,751	1,114,034
CAFARO DEBRA A	Officer	Feb 06 '26	Proposed Sale	$82.23	10,322	848,751	0
CAFARO DEBRA A	Chairman and CEO	Feb 02 '26	Option Exercise	$73.71	10,322	760,835	1,124,356
CAFARO DEBRA A	Chairman and CEO	Feb 02 '26	Sale	$77.66	10,322	801,605	1,114,034

Ventas Inc Aktie (VTR) Neueste Nachrichten

Oct 30, 2026

Ventas, Inc. : Raymond James Raises Target Pr - Moomoo

Oct 30, 2026

Oct 29, 2026

A Look at Ventas Inc (VTR) After 3.3% Gain -- GF Value $76.34 vs Price $83.71 - GuruFocus

Oct 29, 2026

Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch

Oct 29, 2026

Cantor Fitzgerald Maintains Ventas Inc(VTR.US) With Buy Rating, Cuts Target Price to $95 - Moomoo

Oct 29, 2026

Ventas Inc (VTR) (Q3 2026) Earnings Call Highlights: Record NOI Growth, Raised Guidance and a ... - Yahoo Finance

Oct 28, 2026

Ventas Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Oct 28, 2026

Ventas 3Q 2026: Revenue $1.83B, EPS $0.13— 10-Q Summary - TradingView

Oct 28, 2026

Ventas: Q3 Earnings Snapshot - Yahoo Finance

Oct 28, 2026

Ventas Q3 FFO & Revenues Beat Estimates on Strong SHOP Growth - Zacks Investment Research

Oct 28, 2026

Ventas Q3 FFO & Revenues Beat Estimates on Strong SHOP Growth - TradingView

Oct 28, 2026

Ventas, Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:VTR) 2026-10-28 - Seeking Alpha

Oct 28, 2026

Q3 2026 Ventas, Inc. Earnings Call Transcript - GuruFocus

Oct 28, 2026

Ventas, Inc. (VTR) Q3 FY2026 earnings call transcript - Yahoo Finance

Oct 28, 2026

Ventas, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance

Oct 28, 2026

Ventas, Inc. Stock 12‑Month Price Target Cut to $100, Implies 20% Upside - TradingView

Oct 28, 2026

Oct 27, 2026

Ventas (NYSE:VTR) Announces Earnings Results - MarketBeat

Oct 27, 2026

Ventas, Inc. reports results for the quarter ended September 30 - Earnings Summary - TradingView

Oct 27, 2026

Ventas (VTR) Reports Q3 Earnings: What Key Metrics Have to Say - Zacks Investment Research

Oct 27, 2026

Ventas (VTR) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance

Oct 27, 2026

Ventas Q3 earnings, revenue beat on senior housing organic growth - TradingView

Oct 27, 2026

Ventas Inc. stock outperforms competitors despite losses on the day - MarketWatch

Oct 27, 2026

VENTAS ($VTR) Releases Q3 2026 Earnings - Quiver Quantitative

Oct 27, 2026

Ventas Q3 Normalized FFO, Revenue Rise - www.marketscreener.com

Oct 27, 2026

Ventas, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 - www.marketscreener.com

Oct 27, 2026

(VTR) Ventas Now Expects 2026 Normalized FFO Range $3.87-$3.90 - marketscreener.com

Oct 27, 2026

Earnings Flash (VTR) Ventas, Inc. Reports Q3 Revenue $1.83B, vs. FactSet Est of $1.77B - marketscreener.com

Oct 27, 2026

Ventas (VTR) Q3 FFO and Revenues Top Estimates - Zacks Investment Research

Oct 27, 2026

Ventas (VTR) Q3 FFO and Revenues Top Estimates - Yahoo Finance

Oct 27, 2026

Ventas Reports 2026 Third Quarter Results - Business Wire

Oct 27, 2026

Ventas Falls as Investors Appear to Brace for Earnings and Digest a Recent Target Cut - Quiver Quantitative

Oct 27, 2026

Ventas faces earnings test as senior housing boom meets rate pressure - Investing.com Canada

Oct 27, 2026

Oct 26, 2026

Equinix to Post Q3 Earnings: What's in Store for the Stock? - Zacks Investment Research

Oct 26, 2026

BXP to Post Q3 Earnings: Is the Stock a Portfolio Must-Have? - Zacks Investment Research

Oct 26, 2026

Oct 23, 2026

What's in the Offing for Ventas Stock This Earnings Season? - Zacks Investment Research

Oct 23, 2026

What's in the Offing for Ventas Stock This Earnings Season? - TradingView

Oct 23, 2026

Welltower Gears Up to Report Q3 Earnings: What's in the Cards? - Zacks Investment Research

Oct 23, 2026

What to Expect From Ventas’ Q3 2026 Earnings Report - Barchart.com

Oct 23, 2026

Oct 22, 2026

Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch

Oct 22, 2026

Are You Looking for a High-Growth Dividend Stock? - Zacks Investment Research

Oct 22, 2026

Are You Looking for a High-Growth Dividend Stock? - Yahoo Finance

Oct 22, 2026

Oct 21, 2026

19,741 Ventas, Inc. $VTR Shares Bought by Sumitomo Mitsui DS Asset Management Company Ltd - MarketBeat

Oct 21, 2026

Oct 20, 2026

Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch

Oct 20, 2026

Wells Fargo cuts target for Ventas stock to USD 96 - ad-hoc-news.de

Oct 20, 2026

VTR Q3'26 Earnings: revenue estimate is 1.77B USD - TradingView

Oct 20, 2026

Ventas (VTR) Projected to Post Quarterly Earnings on Tuesday - MarketBeat

Oct 20, 2026

Oct 19, 2026

Ventas Price Target Cut to $96.00/Share From $104.00 by Wells Fargo - Moomoo

Oct 19, 2026

Ventas, Inc. acquired HarborChase of Palm Beach Gardens from Silverstone Healthcare Company, LLC for $28.6 million. - www.marketscreener.com

Oct 19, 2026

Ähnlich wie VTR

Ventas Inc (VTR)

Ventas Inc Aktie (VTR) Unternehmensprofil

VTR vs. WELL, OHI, DOC, AHR vergleichen

Ventas Inc Aktie (VTR) Hochstufungen & Herabstufungen

Finanzdaten der Ventas Inc-Aktie (VTR)

Ventas Inc-Aktie (VTR) Insiderhandel

Ventas Inc Aktie (VTR) Neueste Nachrichten

Ventas, Inc. : Raymond James Raises Target Pr - Moomoo

A Look at Ventas Inc (VTR) After 3.3% Gain -- GF Value $76.34 vs Price $83.71 - GuruFocus

Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch

Cantor Fitzgerald Maintains Ventas Inc(VTR.US) With Buy Rating, Cuts Target Price to $95 - Moomoo

Ventas Inc | 10-Q: Q3 2026 Earnings Report - Moomoo

What Ventas (VTR) Said on Its Q3 Earnings Call - TradingView

Ventas, Inc. (VTR) Stock Forecasts - Yahoo Finance

Ventas Inc (VTR) (Q3 2026) Earnings Call Highlights: Record NOI Growth, Raised Guidance and a ... - Yahoo Finance

Ventas Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Ventas 3Q 2026: Revenue $1.83B, EPS $0.13— 10-Q Summary - TradingView

Ventas: Q3 Earnings Snapshot - Yahoo Finance

Ventas Q3 FFO & Revenues Beat Estimates on Strong SHOP Growth - Zacks Investment Research

Ventas Q3 FFO & Revenues Beat Estimates on Strong SHOP Growth - TradingView

Ventas, Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:VTR) 2026-10-28 - Seeking Alpha

Q3 2026 Ventas, Inc. Earnings Call Transcript - GuruFocus

Ventas, Inc. (VTR) Q3 FY2026 earnings call transcript - Yahoo Finance

Ventas, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance

Ventas, Inc. Stock 12‑Month Price Target Cut to $100, Implies 20% Upside - TradingView

Ventas (NYSE:VTR) Announces Earnings Results - MarketBeat

Ventas, Inc. reports results for the quarter ended September 30 - Earnings Summary - TradingView

Ventas (VTR) Reports Q3 Earnings: What Key Metrics Have to Say - Zacks Investment Research

Ventas (VTR) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance

Ventas Q3 earnings, revenue beat on senior housing organic growth - TradingView

Ventas Inc. stock outperforms competitors despite losses on the day - MarketWatch

VENTAS ($VTR) Releases Q3 2026 Earnings - Quiver Quantitative

Ventas Q3 Normalized FFO, Revenue Rise - www.marketscreener.com

Ventas, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 - www.marketscreener.com

(VTR) Ventas Now Expects 2026 Normalized FFO Range $3.87-$3.90 - marketscreener.com

Earnings Flash (VTR) Ventas, Inc. Reports Q3 Revenue $1.83B, vs. FactSet Est of $1.77B - marketscreener.com

Ventas (VTR) Q3 FFO and Revenues Top Estimates - Zacks Investment Research

Ventas (VTR) Q3 FFO and Revenues Top Estimates - Yahoo Finance

Ventas Reports 2026 Third Quarter Results - Business Wire

Ventas Falls as Investors Appear to Brace for Earnings and Digest a Recent Target Cut - Quiver Quantitative

Ventas faces earnings test as senior housing boom meets rate pressure - Investing.com Canada

Equinix to Post Q3 Earnings: What's in Store for the Stock? - Zacks Investment Research

BXP to Post Q3 Earnings: Is the Stock a Portfolio Must-Have? - Zacks Investment Research

What's in the Offing for Ventas Stock This Earnings Season? - Zacks Investment Research

What's in the Offing for Ventas Stock This Earnings Season? - TradingView

Welltower Gears Up to Report Q3 Earnings: What's in the Cards? - Zacks Investment Research

What to Expect From Ventas’ Q3 2026 Earnings Report - Barchart.com

Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch

Are You Looking for a High-Growth Dividend Stock? - Zacks Investment Research

Are You Looking for a High-Growth Dividend Stock? - Yahoo Finance

19,741 Ventas, Inc. $VTR Shares Bought by Sumitomo Mitsui DS Asset Management Company Ltd - MarketBeat

Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch

Wells Fargo cuts target for Ventas stock to USD 96 - ad-hoc-news.de

VTR Q3'26 Earnings: revenue estimate is 1.77B USD - TradingView

Ventas (VTR) Projected to Post Quarterly Earnings on Tuesday - MarketBeat

Ventas Price Target Cut to $96.00/Share From $104.00 by Wells Fargo - Moomoo

Ventas, Inc. acquired HarborChase of Palm Beach Gardens from Silverstone Healthcare Company, LLC for $28.6 million. - www.marketscreener.com

Ähnlich wie VTR